Why did this ASX All Ords stock just crash 16%?

Investors are punishing this ASX All Ords stock on Thursday. But why?

| More on:
Scientist looking at a laptop thinking about the share price performance.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The All Ordinaries Index (ASX: XAO) is down 0.8% in morning trade, and it's certainly not being helped by this tumbling ASX All Ords stock.

The company in question is ASX healthcare stock Avita Medical Inc (ASX: AVH).

The Avita Medical share price closed yesterday trading for $4.50. In early morning trade on Thursday, shares crashed to $3.77, down a precipitous 16.3%.

Following some potential bargain hunting, shares have since recouped some of those losses.

At the time of writing, shares in the ASX All Ords stock are trading for $4.00 apiece, down 11.1%.

Here's what's happening.

ASX All Ords stock tumbles on missed guidance

Avita Medical is a commercial-stage regenerative medicine company focused on devices for wound care management and skin restoration.

And the ASX All Ords stock is under heavy selling pressure today after reaffirming management's expectations for full-year 2024 revenue to come in at the lower end of Avita's previously provided guidance of US$78.5 million to US$84.5 million.

The company also announced an update to its expected commercial revenue for the first quarter of 2024.

For the March quarter, Avita Medical said it now expects commercial revenue to be in the range of US$11.0 million to US$11.3 million. That's significantly lower than the company's prior revenue guidance of US$14.8 million to US$15.6 million for the three-month period.

Management pointed to a slower-than-expected conversion rate of new accounts for Avita's expanded label of full-thickness skin defects for the downward revision.

Commenting on the results putting the ASX All Ords stock under the gun today, Avita Medical CEO Jim Corbett said, "In light of the challenges encountered in the first quarter of 2024, we are intensifying our efforts to drive growth."

Corbett added:

While our account conversion rate impacted our quarterly revenue, we remain optimistic for the full year.

With the recent launch of PermeaDerm in March and the upcoming launch of RECELL GO, along with our deeper understanding of the VAC processes and timelines, we believe that we will meet the lower end of our previously provided annual revenue guidance range of US$78.5 million to US$84.5 million.

Corbett said that Avita remains committed to delivering value and making a positive impact on the lives of its patients.

The company is expected to report its financial results for the first quarter of 2024 after the close of the US financial markets on 13 May, meaning we should have them here at market open on 14 May.

Avita Medical share price snapshot

Despite today's big fall, shares in the ASX All Ords stock remain up 8% over six months.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Avita Medical. The Motley Fool Australia has recommended Avita Medical. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Fallers

A woman with a sad face looks to be receiving bad news on her phone as she holds it in her hands and looks down at it.
Share Fallers

Why Clearview, Loyal Lithium, Polynovo, and Weebit Nano shares are falling

These shares are ending the week deep in the red. But why?

Read more »

A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
Share Fallers

Why IDP Education, JB Hi-Fi, PYC, and Renascor shares are falling today

These shares are missing out on the good times on Thursday. But why?

Read more »

A woman with a sad face looks to be receiving bad news on her phone as she holds it in her hands and looks down at it.
Share Fallers

Why Fletcher Building, Healius, Iperionx, and Iress shares are sinking today

These shares are having a tough time on hump day. But why?

Read more »

A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
Share Fallers

Why Boss Energy, Meteoric Resources, Pantoro, and Worley shares are falling today

These shares are having a tough session today. But why?

Read more »

Bored man sitting at his desk with his laptop.
Share Fallers

Why ANZ, Fletcher Building, Macquarie, and Sayona Mining shares are dropping today

These ASX shares are starting the week in the red. But why?

Read more »

A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
Share Fallers

Why Cettire, De Grey Mining, Life360, and Neuren shares are falling today

These ASX shares are ending the week in the red. But why?

Read more »

Scientist looking at a laptop thinking about the share price performance.
Healthcare Shares

Why this high-flying ASX 200 healthcare stock just crashed 11%

Neuren Pharmaceuticals just dropped its 1Q FY24 report on DAYBUE sales.

Read more »

a man weraing a suit sits nervously at his laptop computer biting into his clenched hand with nerves, and perhaps fear.
Share Fallers

Why Baby Bunting, JB Hi-Fi, Temple & Webster, and Westpac shares are falling today

These ASX shares are having a very tough session. What's going on?

Read more »